Company Filing History:
Years Active: 2004
Title: Wesley Todd White: Innovator in Pharmaceutical Research
Introduction
Wesley Todd White is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of methods and compounds for inhibiting MRP1. His work has the potential to impact therapeutic strategies for various medical conditions.
Latest Patents
Wesley Todd White holds a patent for "Methods and compounds for inhibiting MRP1." This invention relates to a method of inhibiting MRP1 in a mammal, which involves administering an effective amount of a compound of formula (I) to a mammal in need thereof. This patent showcases his innovative approach to addressing critical health issues.
Career Highlights
Wesley Todd White is associated with Eli Lilly and Company, a leading global pharmaceutical company. His role at Eli Lilly has allowed him to work on groundbreaking research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
Wesley has collaborated with esteemed colleagues such as Rosanne Bonjouklian and Jeffrey Daniel Cohen. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Wesley Todd White's contributions to pharmaceutical research and his innovative patent for inhibiting MRP1 highlight his commitment to advancing medical science. His work at Eli Lilly and his collaborations with other professionals underscore the importance of teamwork in achieving significant breakthroughs in healthcare.